A new drug trialled by research staff at South Tees Hospitals NHS Foundation Trust has been found to reduce deaths from COVID-19 by a fifth in the sickest patients.
Throughout the COVID-19 pandemic many patients at The James Cook University Hospital have had their heart valve replaced and then gone home again the same day. Their speedy recovery has been made possible thanks to an advanced procedure called TAVI (transcatheter aortic valve implantation) which avoids the need for open heart surgery.
A scientific and medical team led by Newcastle University, UK, have demonstrated that the gene, HLA-DRB1*04:01, is found three times as often in people who are asymptomatic. This suggests that people with this gene have some level of protection from severe COVID.